Format

Send to

Choose Destination
Aging (Albany NY). 2014 Oct;6(10):788-819.

Eryptosis as a marker of Parkinson's disease.

Author information

1
Department of Physiology, Faculty of Health Sciences, University of Pretoria, Arcadia 0007, South Africa.
2
Microscopy and Microanalysis Unit, University of Pretoria, Arcadia 0007, South Africa.
3
Department of Neurology Faculty of Health Sciences, University of Pretoria, Arcadia 0007, South Africa.
4
School of Chemistry and The Manchester Institute of Biotechnology, The University of Manchester, Manchester M1 7DN, Lancs, UK.

Abstract

A major trend in recent Parkinson's disease (PD) research is the investigation of biological markers that could help in identifying at-risk individuals or to track disease progression and response to therapies. Central to this is the knowledge that inflammation is a known hallmark of PD and of many other degenerative diseases. In the current work, we focus on inflammatory signalling in PD, using a systems approach that allows us to look at the disease in a more holistic way. We discuss cyclooxygenases, prostaglandins, thromboxanes and also iron in PD. These particular signalling molecules are involved in PD pathophysiology, but are also very important in an aberrant coagulation/hematology system. We present and discuss a hypothesis regarding the possible interaction of these aberrant signalling molecules implicated in PD, and suggest that these molecules may affect the erythrocytes of PD patients. This would be observable as changes in the morphology of the RBCs and of PD patients relative to healthy controls. We then show that the RBCs of PD patients are indeed rather dramatically deranged in their morphology, exhibiting eryptosis (a kind of programmed cell death). This morphological indicator may have useful diagnostic and prognostic significance.

PMID:
25411230
PMCID:
PMC4247384
DOI:
10.18632/aging.100695
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Impact Journals, LLC Icon for PubMed Central
Loading ...
Support Center